Treatment for Posttraumatic Stress Disorder
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
AbstractOBJECTIVE:To thoroughly and critically review the pharmacologic treatment of posttraumatic stress disorder (PTSD) and to review the symptomatology, diagnosis, epidemiology, pathophysiology, and assessment of PTSD.DATA SOURCES:A MEDLINE search (1966–October 1999) in the English language specifying PTSD drug treatment as the search term was used to identify articles.STUDY SELECTION AND DATA EXTRACTION:All articles identified were reviewed; emphasis was given to randomized, double-blind, placebo-controlled studies.DATA SYNTHESIS:It appears that a five-week medication trial is necessary to assess clinical effects on PTSD symptoms. The monoamine oxidase inhibitors appear to be superior to the tricyclic antidepressants in improving reexperiencing and avoidance symptoms. Most studies used assessment tools that neglected hyperarousal symptoms; therefore, no conclusions regarding this symptom cluster can be drawn. Other pharmacotherapeutic interventions reported in open-label trials have yielded varying success.CONCLUSIONS:The current literature does not bear a sufficient number of double-blind, placebo-controlled studies using assessment tools that evaluate the three symptom clusters of PTSD to allow for a definite treatment modality to be formulated. Nonetheless, a treatment hierarchy appears to be in order based on the greatest number of double-blind, placebo-controlled studies evaluating antidepressants. Alternate modalities such as mood stabilizers, antipsychotics, anxiolytics, and adrenergic blockers should not be considered the mainstays of therapy. ResumenOBJETIVO:Hacer una revisión detallada del tratamiento farmacológico del Desorden por Stress Postraumático (DSPT). También, revisar la sintomatologia, diagnóstico, epidemiología, y fisiopatología del DSPT como base para la evaluación de la literatura farmacoterapéutica.FUENTES DE INFORMACIÓN:Investigación de la base de datos MEDLINE para identificar literatura en inglés extendiéndose del año 1966 hasta el presente. Los términos clave utilizados fueron tratamiento farmacológico del DSPT.SELECCIÓN DE FUENTES DE INFORMACIÓN Y MÉTODO DE EXTRACCIÓN DE DATOS:Se hizo una revisión detallada, sobretodo de los estudios de asignación de tratamiento al azar, en doble ciego, y controlados con placebo. Cada estudio evaluado fue resumido para esta revisión. Los estudios de diseño abierto fueron presentados en forma de tabla, y los reportes de casos individuales fueron citados en el texto principal del artículo.SÍNTESIS:Parece ser que un tratamiento farmacológico de prueba de cinco semanas es necesario para evaluar los efectos clínicos del tratamiento del DSPT. Los inhibidores de la monoamino oxidasa parecen ser superiores a los antidepresores tricíclicos en cuanto a la mejora de los síntomas del DSPT. La mayoría de los estudios revisados fallaron en emplear instrumentos que evaluasen los síntomas de sobreexitación al despertarse, de tal modo que no se sabe cómo el tratamiento medicamentoso afecta estos síntomas. Otras intervenciones farmacoterapéuticas reportadas en estudios de diseño abierto dieron resultados variados.CONCLUSIONES:La literatura actual carece del número necesario de estudios en doble ciego y controlados con placebo que usen instrumentos adecuados para evaluar el grupo de síntomas típicos del DSPT. Como consecuencia, es difícil determinar cual es la modalidad de tratamiento más efectiva para el control de esta condición. Sin embargo, la disponibilidad de un mayor número de estudios bien controlados usando antidepresores pone a estos agentes a la cabeza de la lista. Otras modalidades de tratamiento, tales como, los estabilizadores del humor, antipsicóticos, ansiolíticos, y bloqueadores adrenérgicos no deberían ser recomendados como soporte principal del tratamiento. RésuméOBJECTIF:Réviser et analyser en profondeur le traitement pharmacologique du stress post-traumatique (SPT). De façon plus spécifique et afin de faciliter l'analyse de l'information, les auteurs décrivent la symptomatologie, le diagnostic, l'épidémiologie, la pathophysiologie, et l'évaluation de l'état de SPT.SOURCE DE L'INFORMATION:Une recherche sur MEDLINE en langue anglaise a été effectuée pour la période allant de 1966 jusqu'à maintenant en recherchant particulièrement les mots-clés suivants SPT drug treatment.SÉLECTION DES ÉTUDES:Tous les articles identifiés lors de la recherche ont été révisés. Une attention particulière a été apportée aux études contrôlées et à double insu. Les études ouvertes ont été énumérées sous forme de tableau et les histoires de cas sont citées dans le texte.RÉSUMÉ:Il découle de la littérature qu'un essai thérapeutique de cinq semaines est nécessaire pour évaluer l'efficacité clinique d'un médicament sur les symptômes de SPT. Les inhibiteurs de la monoamine oxydase semblent plus efficaces que les antidépresseurs tricycliques pour améliorer les souvenirs répétitifs et les comportements d'évitement. La majorité des études ont utilisé des outils d'évaluatio
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brown, G., Albers, J. J., Fisher, L. D., Schaefer, S. M., Lin, J.-T., Kaplan, C., Zhao, X.-Q., Bisson, B. D., Fitzpatrick, V. F., & Dodge, H. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231901 · Cited by 2,159
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.7.973 · Cited by 1,610
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.1.83 · Cited by 517
Low urinary cortisol excretion in Holocaust survivors with posttraumatic stress disorder
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.7.982 · Cited by 499
Post-traumatic stress disorder and depression: An analysis of comorbidity
Bleich, A., Koslowsky, M., Dolev, A., & Lerer, B. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.170.5.479 · Cited by 211
Withdrawal syndrome in a depressed patient treated with trazodone
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.9.1195a · Cited by 12
Cited by
Monoamine oxidase inactivation: from pathophysiology to therapeutics
Bortolato, M., Chen, K., & Shih, J. C. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.06.002 · Cited by 634
Pharmacotherapy for post traumatic stress disorder (PTSD)
Stein, D. J., Ipser, J. C., Seedat, S., Sager, C., & Amos, T. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002795.pub2 · Cited by 519
Clinical Pharmacology of MAO Inhibitors: Safety and Future
Yamada, M. (2004) · NeuroToxicology · doi:10.1016/s0161-813x(03)00097-4 · Cited by 324
Cates, M. E., Bishop, M. H., Davis, L. L., Lowe, J. S., & Woolley, T. W. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1e043 · Cited by 105
Metadata
- Authors
- Cyr, M., & Farrar, M. K.
- Venue
- The Annals of Pharmacotherapy
- Publisher
- SAGE Publications
- Published
- 2000-03
- Volume
- 34
- Issue
- 3
- Pages
- 366-376
- ISSN
- 0012-6578 (ISSN-L)
- 1060-0280
- 1542-6270
- OpenAlex
- W2145542690
- Cited by
- 43
- References
- 6
- FWCI
- 3.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment for Posttraumatic Stress Disorder. https://app.cochat.ai/papers/10.1345/1542-6270(2000)034%3C0366:tfpsd%3E2.3.co;2
- The paper
- Cyr, M., & Farrar, M. K. (2000). Treatment for Posttraumatic Stress Disorder. The Annals of Pharmacotherapy. https://doi.org/10.1345/1542-6270(2000)034%3C0366%3Atfpsd%3E2.3.co%3B2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.